David D. Phinney

David Phinney, J.D., serves as consulting General Counsel at Abintus. He is a partner at Adkins Black LLP, with a focus on life sciences, software, technology transactions and intellectual property law. Prior to joining Adkins Black, David was Associate General Counsel for Caradigm, a Microsoft-GE joint venture, and a senior associate in the technology transactions practice at Wilson Sonsini Goodrich & Rosati, where he represented clients in the negotiation and execution of numerous complex transactions related to the development and commercialization of intellectual property, primarily in the life sciences, software, and technology industries. He also served as vice president of legal affairs for Angiotech Pharmaceuticals, a global specialty pharmaceutical and medical device company. Prior to joining Angiotech, David was an associate at Heller Ehrman and a patent agent at a boutique patent law firm in the Silicon Valley. David obtained his J.D. from Stanford Law School and B.S. and M.S. degrees in biology from the University of Washington.